Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07445035
Recruiting Not applicable

Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation

NCT07445035 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Fu Jen Catholic University
Phase
Not applicable
Started
2026-06-26
Last updated
2026-07-01

Condition(s) studied

Prolonged Mechanical VentilationVentilator WeaningVentilator DependentExoskeleton DeviceExercise Training

Investigational drug(s) / intervention(s)

lower-limb exoskeletonStandard medical treatment

lower-limb exoskeleton: regular therapy plus exoskeleton training

Standard medical treatment: regular therapy

Study summary

This study aims to evaluate the effects of powered lower-limb exoskeleton-assisted training on lower limb strength, respiratory parameters, 28-day ventilator-free days, and length of hospital stay in patients with prolonged mechanical ventilation admitted to a Respiratory Care Center. The goal is to provide clinical evidence for integrating rehabilitation and respiratory care in this patient population.

Eligibility

Sex
ALL
Min age
45 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Able to maintain a seated position for at least 1 minute. * The participant or their legal representative is able to sign the informed consent form. Exclusion Criteria: * Inability to follow instructions. * Intubation/tracheostomy prior to current admission. * Diagnosis of severe left heart failure. * Diagnosis of neuromuscular disorders. * Unable to stand. * Complete paralysis of the lower extremities. * Presence of unhealed ulcers in the lower extremities. * Deep vein thrombosis of the lower extremities. * Lower-limb amputation. * Severe hypertension * Severe cardiac conditions * Severe bilateral joint disorders * Severe pain while standing * Severe osteoporosis * Lower-limb fracture * Ongoing epileptic seizure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fu Jen Catholic University Hospital, Fu Jen Catholic University New Taipei City Taiwan Recruiting

More Fu Jen Catholic University trials in Taiwan

Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease Recruiting
Multimodal Deep Learning Model for Predicting the Apnea-Hypopnea Index in Obstructive Sleep Recruiting
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease Recruiting
AI-Powered Virtual Human Simulation in Students Starting soon
Use of 3D Printing High-fidelity Craniofacial Manikin to Teach Noninvasive Positive Pressure Ventilation Recruiting

Other trials for the same condition

Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07445035 on ClinicalTrials.gov ↗ ← All trials in Taiwan